C4 Imaging LLC

C4 Imaging LLC develops advanced medical devices that enhance patient care through precise imaging techniques, focusing on innovative solutions for oncology treatments. C4 Imaging LLC specializes in creating medical imaging devices. The company is headquartered in Houston, US. Founded by Steven Frank and currently led by CEO Andrew Bright, C4 Imaging has undergone no significant pivots in its business strategy since its inception.

C4 Imaging specializes in the development of cutting-edge medical devices designed to enhance patient care through precise image-guided procedures. Their flagship products include the Sirius® MRI Marker and the Orion™ HDR MRI Marker. The Sirius® MRI Marker is specifically engineered to improve seed localization during prostate cancer treatments utilizing low dose rate (LDR) radioactive seeds, allowing clinicians to identify seed placement accurately via a single post-implant MRI. In contrast, the Orion™ HDR MRI Marker is utilized in the positioning of high dose rate (HDR) brachytherapy catheters, applicable in various cancer treatments.

Both products leverage C4 Imaging's proprietary MRI agent encapsulated within biocompatible shells, addressing critical clinical needs in oncology. The company's offerings primarily serve hospitals and cancer treatment centers across North America and Europe, where medical professionals are focused on enhancing treatment precision and patient outcomes. C4 Imaging operates through a direct sales model, engaging healthcare institutions and oncology practices as their primary clients. Each transaction typically involves the sale of their proprietary products, with an emphasis on the Sirius® and Orion™ MRI Markers.

The pricing structure for these products is determined based on individual contracts negotiated with hospitals and treatment centers, which may include volume-based pricing or tiered discounts for bulk purchases. Revenue generation is predominantly derived from the direct sales of these flagship products, supporting oncologists in delivering advanced treatment options. Partnerships with medical distributors may also play a role in their transaction framework, facilitating broader market access and enabling healthcare providers to integrate C4 Imaging's innovative solutions into their treatment protocols.